Financials
- Market Capitalization 13.1 B
- Employee 730
- Founded 1998
- CEO N/A
- Website www.corcept.com
- Headquarter Delaware, United States
- FIGI BBG000BKJG33
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
42.44
Relación precio/flujo de caja
5.48
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 707 | ASND Ascendis Pharma A/S - American Depositary Shares | 227.00 USD | -0.97% | -0.96% | -14.34% | +10.69% | 14.07 B USD | ||
| 721 | SMMT Summit Therapeutics Inc. - Common Stock | 17.13 USD | -2.62% | -2.11% | -5.20% | -13.75% | 13.67 B USD | ||
| 752 | BBIO BridgeBio Pharma, Inc. - Common Stock | 65.75 USD | +0.61% | -3.17% | -9.37% | +15.35% | 12.85 B USD | ||
| 770 | HALO Halozyme Therapeutics, Inc. - Common Stock | 111.08 USD | +0.60% | +2.03% | +2.85% | +66.29% | 12.61 B USD |